This company offers a clinical-grade DNA test that uses AI and machine learning to identify genetic risks for diseases like cancer and heart disease. The test provides actionable health insights, enabling early detection and better-informed healthcare decisions.
Funding
Funding not disclosed
Founders
Product
Problem
Many individuals are unaware of their genetic predispositions to various diseases, including hereditary cancers and heart conditions, until the onset of symptoms, which can delay proactive intervention and personalized treatment. Existing genetic tests may lack comprehensive coverage across diverse ethnicities and may not provide clinical-grade reporting with mutation-level evidence.
Solution
SugarStrings.ai offers HEALTHSTRING, a clinical-grade preventive genetic test that decodes the root causes of over 6,000 diseases with clinical-grade accuracy. The test utilizes machine learning to identify genetic risks for a wide range of conditions, including hereditary cancers, heart diseases, and drug responses. HEALTHSTRING provides comprehensive DNA screening and clinical-grade reporting, enabling early detection and personalized healthcare decisions. The test is designed to be accurate across diverse ethnicities, ensuring broad applicability. By identifying risks before disease develops, HEALTHSTRING facilitates proactive and preventive care, allowing for personalized medication and targeted treatment.
Target Audience
The primary target audience includes individuals with a family history of diseases, those planning a family, individuals with unresolved health conditions, and those seeking to proactively preserve their health.
Features
- Comprehensive DNA screening for over 6,000 diseases, including 100 hereditary cancers and 105 heart diseases
- Clinical-grade reporting with DNA mutation-level evidence
- Polygenic and monogenic risk identification
- Accurate across diverse ethnicities
- Machine learning-powered analysis for identifying genetic predispositions
- Identifies 3,500+ disease carrier profiles and 300+ drug responses
- Compliant with global guidelines